| 2026-11-13 | Complete response letter | complete response | Summit Therapeutics Inc. SMMT | SMT112 | CRL 2026-11-13: Summit Therapeutics Inc. BLA 761524 (AK112/SMT112 (also referred to by the Applicant as ivonescimab)) |
| 2026-11-13 | FDA approval | approved | TEVA TEVA | IGALMI | Approved 2026-11-13: IGALMI (NDA215390 SUPPL3) |
| 2026-11-13 | FDA approval | approved | GENENTECH | GAZYVA | Approved 2026-11-13: GAZYVA (BLA125486 SUPPL44) |
| 2026-11-13 | FDA approval | approved | ASTRAZENECA UK LTD AZN | IMFINZI | Approved 2026-11-13: IMFINZI (BLA761069 SUPPL59) |
| 2026-11-13 | FDA approval | approved | ALEXION PHARM | KLYGEFA | Approved 2026-11-13: KLYGEFA (BLA761488 ORIG1) |
| 2026-11-13 | FDA approval | approved | CYTOKINETICS CYTK | MYQORZO | Approved 2026-11-13: MYQORZO (NDA219083 SUPPL2) |
| 2026-11-13 | FDA approval | approved | BIOGEN BIIB | ZURZUVAE | Approved 2026-11-13: ZURZUVAE (NDA217369 SUPPL4) |
| 2026-11-12 | FDA approval | approved | BIOCON BIOLOGICS INC | PEBRILZO | Approved 2026-11-12: PEBRILZO (BLA761501 ORIG1) |
| 2026-11-10 | FDA approval | approved | EMD SERONO | PIMJETMI | Approved 2026-11-10: PIMJETMI (NDA220414 ORIG1) |
| 2026-11-10 | FDA approval | approved | CMG PHARM CO LTD | MEZOFY | Approved 2026-11-10: MEZOFY (NDA211448 SUPPL1) |
| 2026-11-09 | FDA approval | approved | AVYXA HOLDINGS | OXDERYS | Approved 2026-11-09: OXDERYS (NDA221093 ORIG1) |
| 2026-11-09 | FDA approval | approved | BAYER HEALTHCARE | SUNHARBO | Approved 2026-11-09: SUNHARBO (NDA221291 ORIG1) |
| 2026-11-09 | FDA approval | approved | FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC FMS | MULTIBIC | Approved 2026-11-09: MULTIBIC (NDA219457 ORIG1) |
| 2026-11-09 | PDUFA date (company-disclosed) | date passed | Immunome Inc. IMNM | | PDUFA November 9, 2026 - Immunome Inc. |
| 2026-11-05 | FDA approval | approved | JANSSEN BIOTECH | RYBREVANT FASPRO | Approved 2026-11-05: RYBREVANT FASPRO (BLA761433 SUPPL2) |
| 2026-11-01 (month) | PDUFA date (company-disclosed) | date passed | MoonLake Immunotherapeutics MLTX | | PDUFA November 2026 - MoonLake Immunotherapeutics |
| 2026-10-30 | FDA AdCom | held | Sydnexis | | AdCom 2026-10-30: Dermatologic and Ophthalmic Drugs Advisory Committee - NDA 219694 |
| 2026-10-30 | PDUFA date (company-disclosed) | date passed | INOVIO PHARMACEUTICALS, INC. INO | | PDUFA October 30, 2026 - INOVIO PHARMACEUTICALS, INC. |
| 2026-10-29 | FDA approval | approved | AVYXA HOLDINGS | AXYCIS | Approved 2026-10-29: AXYCIS (NDA220748 ORIG1) |
| 2026-10-29 | FDA approval | approved | SUN PHARMA GLOBAL | ILUMYA | Approved 2026-10-29: ILUMYA (BLA761067 SUPPL31) |
| 2026-10-27 | FDA approval | approved | XBRANE BIOPHARMA AB | LUCAMZI | Approved 2026-10-27: LUCAMZI (BLA761187 ORIG1) |
| 2026-10-26 | FDA approval | approved | PFIZER PFE | TALZENNA | Approved 2026-10-26: TALZENNA (NDA217439 SUPPL4) |
| 2026-10-26 | FDA approval | approved | PFIZER PFE | TALZENNA | Approved 2026-10-26: TALZENNA (NDA211651 SUPPL14) |
| 2026-10-23 | FDA approval | approved | PHARMACOSMOS | MONOFERRIC | Approved 2026-10-23: MONOFERRIC (NDA208171 SUPPL6) |
| 2026-10-23 | FDA approval | approved | NOVO NORDISK INC NVO | AWIQLI FLEXTOUCH | Approved 2026-10-23: AWIQLI FLEXTOUCH (BLA761326 SUPPL1) |
| 2026-10-23 | FDA approval | approved | ABBVIE INC ABBV | SKYRIZI | Approved 2026-10-23: SKYRIZI (BLA761105 SUPPL53) |
| 2026-10-22 | FDA approval | approved | AMGEN INC AMGN | PAVBLU | Approved 2026-10-22: PAVBLU (BLA761298 ORIG2) |
| 2026-10-22 | FDA approval | approved | FORMYCON AG | AHZANTIVE | Approved 2026-10-22: AHZANTIVE (BLA761378 ORIG2) |
| 2026-10-22 | FDA approval | approved | SANDOZ INC | ENZEEVU | Approved 2026-10-22: ENZEEVU (BLA761382 ORIG2) |
| 2026-10-21 | FDA approval | approved | ALEXION PHARM | ULTOMIRIS | Approved 2026-10-21: ULTOMIRIS (BLA761108 SUPPL46) |
| 2026-10-20 | FDA approval | approved | GLAXOSMITHKLINE | HIBSAGO | Approved 2026-10-20: HIBSAGO (NDA221276 ORIG1) |
| 2026-10-19 | FDA approval | approved | GLAXOSMITHKLINE | JEMPERLI | Approved 2026-10-19: JEMPERLI (BLA761174 SUPPL15) |
| 2026-10-19 | FDA approval | approved | FRESENIUS MEDCL CARE | CIENBY | Approved 2026-10-19: CIENBY (NDA219455 ORIG1) |
| 2026-10-19 | FDA approval | approved | FRESENIUS MEDCL CARE | CALREZDY | Approved 2026-10-19: CALREZDY (NDA219456 ORIG1) |
| 2026-10-16 | FDA approval | approved | BLUEPRINT MEDICINES | AYVAKIT | Approved 2026-10-16: AYVAKIT (NDA212608 SUPPL21) |
| 2026-10-16 | FDA approval | approved | FAMYGEN LIFE SCI | RYZUMVI | Approved 2026-10-16: RYZUMVI (NDA217064 SUPPL5) |
| 2026-10-16 | FDA approval | approved | ROSEMONT PHARMS | YULZETY | Approved 2026-10-16: YULZETY (NDA221033 ORIG1) |
| 2026-10-16 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA | Approved 2026-10-16: KEYTRUDA (BLA125514 SUPPL191) |
| 2026-10-16 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA QLEX | Approved 2026-10-16: KEYTRUDA QLEX (BLA761467 SUPPL8) |
| 2026-10-16 | FDA approval | approved | ALCON LABS INC ALC | BRYTLY | Approved 2026-10-16: BRYTLY (NDA220341 ORIG1) |
| 2026-10-15 | FDA approval | approved | GENENTECH | ENSPRYNG | Approved 2026-10-15: ENSPRYNG (BLA761149 SUPPL8) |
| 2026-10-15 | FDA approval | approved | NOVARTIS PHARMS CORP NVS | COSENTYX | Approved 2026-10-15: COSENTYX (BLA761349 SUPPL13) |
| 2026-10-15 | FDA approval | approved | COSETTE | EVOXAC | Approved 2026-10-15: EVOXAC (NDA221183 ORIG1) |
| 2026-10-15 | FDA approval | approved | UCB INC | ZILBRYSQ | Approved 2026-10-15: ZILBRYSQ (NDA216834 SUPPL15) |
| 2026-10-14 | FDA approval | approved | ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU | ANKTIVA | Approved 2026-10-14: ANKTIVA (BLA761336 SUPPL2) |
| 2026-10-14 | FDA approval | approved | MERCK SHARP DOHME MRK | ENFLONSIA | Approved 2026-10-14: ENFLONSIA (BLA761432 SUPPL3) |
| 2026-10-13 | FDA approval | approved | VIFOR FRESENIUS | VELPHORO | Approved 2026-10-13: VELPHORO (NDA205109 SUPPL14) |
| 2026-10-09 | FDA approval | approved | BRACCO | ISOVUE READI | Approved 2026-10-09: ISOVUE READI (NDA220583 ORIG1) |
| 2026-10-09 | FDA approval | approved | AICURIS ANTI-INFECT | HOVILPRI | Approved 2026-10-09: HOVILPRI (NDA221154 ORIG1) |
| 2026-10-09 | FDA approval | approved | ELI LILLY AND CO LLY | OLUMIANT | Approved 2026-10-09: OLUMIANT (NDA207924 SUPPL10) |
| 2026-10-09 | FDA approval | approved | AMGEN INC AMGN | REPATHA | Approved 2026-10-09: REPATHA (BLA125522 SUPPL47) |
| 2026-10-08 | FDA approval | approved | GENENTECH INC | TECENTRIQ HYBREZA | Approved 2026-10-08: TECENTRIQ HYBREZA (BLA761347 SUPPL11) |
| 2026-10-08 | FDA approval | approved | GENENTECH INC | TECENTRIQ | Approved 2026-10-08: TECENTRIQ (BLA761034 SUPPL65) |
| 2026-10-08 | FDA approval | approved | TEVA TEVA | WELTRUZA | Approved 2026-10-08: WELTRUZA (NDA219007 ORIG1) |
| 2026-10-08 | FDA approval | approved | ASTRAZENECA AB AZN | BREZTRI AEROSPHERE | Approved 2026-10-08: BREZTRI AEROSPHERE (NDA220290 ORIG1) |
| 2026-10-07 | FDA approval | approved | SEAGEN | TUKYSA | Approved 2026-10-07: TUKYSA (NDA213411 SUPPL10) |
| 2026-10-06 | FDA approval | approved | NOVARTIS NVS | RHAPSIDO | Approved 2026-10-06: RHAPSIDO (NDA218436 SUPPL1) |
| 2026-10-02 | FDA approval | approved | LOXO ONCOL | JAYPIRCA | Approved 2026-10-02: JAYPIRCA (NDA216059 SUPPL6) |
| 2026-10-01 | FDA AdCom | held | | | AdCom 2026-10-01: Vaccines and Related Biological Products Advisory Committee |
| 2026-10-01 | FDA approval | approved | EVER | TRABECTEDIN | Approved 2026-10-01: TRABECTEDIN (NDA219617 ORIG1) |
| 2026-09-30 | FDA approval | approved | BRISTOL BMY | CAMZYOS | Approved 2026-09-30: CAMZYOS (NDA214998 SUPPL13) |
| 2026-09-30 | PDUFA date (company-disclosed) | date passed | AGIOS PHARMACEUTICALS, INC. AGIO | | PDUFA September 30, 2026 - AGIOS PHARMACEUTICALS, INC. |
| 2026-09-30 | PDUFA date (company-disclosed) | date passed | Scholar Rock Holding Corp SRRK | | PDUFA September 30, 2026 - Scholar Rock Holding Corp |
| 2026-09-28 | FDA approval | approved | RARE THYROID | EMCITATE | Approved 2026-09-28: EMCITATE (NDA220963 ORIG1) |
| 2026-09-25 | FDA approval | approved | ABBVIE ABBV | JUVMO | Approved 2026-09-25: JUVMO; JUVMO (COPACKAGED) (NDA220415 ORIG1) |
| 2026-09-25 | FDA approval | approved | ADVENTAPHARMA | ZUEINO | Approved 2026-09-25: ZUEINO (NDA218379 ORIG1) |
| 2026-09-25 | FDA approval | approved | AZURITY | LAMLIQUE | Approved 2026-09-25: LAMLIQUE (NDA221109 ORIG1) |
| 2026-09-25 | FDA approval | approved | MIRUM MIRM | ATEBRIOZ | Approved 2026-09-25: ATEBRIOZ (NDA221198 ORIG1) |
| 2026-09-25 | FDA approval | approved | GENENTECH | GAZYVA | Approved 2026-09-25: GAZYVA (BLA125486 SUPPL43) |
| 2026-09-25 | FDA approval | approved | ELI LILLY AND CO LLY | OLUMIANT | Approved 2026-09-25: OLUMIANT (NDA207924 SUPPL9) |
| 2026-09-25 | FDA approval | approved | TEVA PHARMACEUTICALS, INC. TEVA | DEGEVMA | Approved 2026-09-25: DEGEVMA (BLA761481 ORIG1) |
| 2026-09-24 | FDA approval | approved | EISAI INC | LENVIMA | Approved 2026-09-24: LENVIMA (NDA206947 SUPPL35) |
| 2026-09-24 | FDA approval | approved | MERCK SHARP DOHME MRK | WELIREG | Approved 2026-09-24: WELIREG (NDA215383 SUPPL13) |
| 2026-09-23 | FDA AdCom | held | | | AdCom 2026-09-23: Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee |
| 2026-09-23 | FDA approval | approved | ELEVAR | LYRFIGTU | Approved 2026-09-23: LYRFIGTU (NDA220425 ORIG1) |
| 2026-09-23 | FDA approval | approved | ELI LILLY AND CO LLY | ONSWIK | Approved 2026-09-23: ONSWIK (BLA761408 ORIG1) |
| 2026-09-22 | FDA approval | approved | AGL WELDING SUPPLY CO INC DBA AGL GAS TECHNOLOGIES | CARBON DIOXIDE USP | Approved 2026-09-22: CARBON DIOXIDE, USP (NDA222000 ORIG1) |
| 2026-09-21 | FDA approval | approved | MERCK SHARP DOHME MRK | WINREVAIR | Approved 2026-09-21: WINREVAIR (BLA761363 SUPPL12) |
| 2026-09-19 | PDUFA date (company-disclosed) | date passed | Ultragenyx Pharmaceutical Inc. RARE | apazunersen | PDUFA September 19, 2026 - Ultragenyx Pharmaceutical Inc. (apazunersen) |
| 2026-09-18 | FDA approval | approved | ELI LILLY AND CO LLY | INLURIYO | Approved 2026-09-18: INLURIYO (NDA218881 SUPPL1) |
| 2026-09-18 | FDA approval | approved | ELI LILLY AND CO LLY | VERZENIO | Approved 2026-09-18: VERZENIO (NDA208716 SUPPL22) |
| 2026-09-18 | FDA approval | approved | INTRABIO | AQNEURSA | Approved 2026-09-18: AQNEURSA (NDA219132 SUPPL2) |
| 2026-09-16 | FDA AdCom | held | | | AdCom 2026-09-16: Pediatric Advisory Committee (PAC) |
| 2026-09-16 | FDA approval | approved | NUVATION NUVB | IBTROZI | Approved 2026-09-16: IBTROZI (NDA219713 SUPPL4) |
| 2026-09-16 | FDA approval | approved | BAYER HLTHCARE | KERENDIA | Approved 2026-09-16: KERENDIA (NDA215341 SUPPL11) |
| 2026-09-16 | FDA approval | approved | ASTRAZENECA AZN | TRUQAP | Approved 2026-09-16: TRUQAP (NDA218197 SUPPL6) |
| 2026-09-15 | FDA approval | approved | EMERGE BIOSCIENCE PTE. LTD. | GARZULYS | Approved 2026-09-15: GARZULYS (BLA761497 ORIG2) |
| 2026-09-14 | FDA approval | approved | ASTRAZENECA AZN | TAGRISSO | Approved 2026-09-14: TAGRISSO (NDA208065 SUPPL35) |
| 2026-09-14 | FDA approval | approved | CURIUM | BEXLUTRY | Approved 2026-09-14: BEXLUTRY (NDA218525 ORIG1) |
| 2026-09-11 | FDA approval | approved | SCHOLAR ROCK INC SRRK | ISEMBYLD | Approved 2026-09-11: ISEMBYLD (BLA761463 ORIG1) |
| 2026-09-11 | FDA approval | approved | TELIX TLX | PIXCLARA | Approved 2026-09-11: PIXCLARA (NDA218592 ORIG1) |
| 2026-09-11 | FDA approval | approved | PHARMING PHAR | JOENJA | Approved 2026-09-11: JOENJA (NDA217759 SUPPL6) |
| 2026-09-09 | Complete response letter | complete response | SEIKAGAKU Corporation | SI-6603 (condoliase) injection | CRL 2026-09-09: SEIKAGAKU Corporation BLA 761393 (SI-6603 (condoliase) injection) |
| 2026-09-09 | FDA approval | approved | BIOFRONTERA BFRI | AMELUZ | Approved 2026-09-09: AMELUZ (NDA208081 SUPPL40) |
| 2026-09-09 | FDA approval | approved | BAYER HEALTHCARE | HYRNUO | Approved 2026-09-09: HYRNUO (NDA219972 SUPPL1) |
| 2026-09-04 | FDA approval | approved | ASTRAZENECA AZN | ETCAMAH | Approved 2026-09-04: ETCAMAH (NDA220359 ORIG1) |
| 2026-09-03 | FDA approval | approved | HANDA ONCOL | OMCAZIO | Approved 2026-09-03: OMCAZIO (NDA220613 ORIG1) |
| 2026-09-03 | FDA approval | approved | IONIS PHARMS INC IONS | ZANVASTRO | Approved 2026-09-03: ZANVASTRO (NDA220210 ORIG1) |
| 2026-08-28 | FDA approval | approved | PHARMAESSENTIA CORP | BESREMI | Approved 2026-08-28: BESREMI (BLA761166 SUPPL13) |
| 2026-08-28 | FDA approval | approved | TAKEDA PHARMS AM TAK | MIMRYLO | Approved 2026-08-28: MIMRYLO (NDA220605 ORIG1) |
| 2026-08-28 | FDA approval | approved | JANSSEN BIOTECH | STELARA | Approved 2026-08-28: STELARA (BLA761044 SUPPL21) |
| 2026-08-27 | FDA approval | approved | ELI LILLY AND CO LLY | MOUNJARO MOUNJARO KWIKPEN | Approved 2026-08-27: MOUNJARO; MOUNJARO (AUTOINJECTOR); MOUNJARO KWIKPEN (NDA215866 SUPPL44) |
| 2026-08-27 | FDA approval | approved | ELI LILLY AND CO LLY | MOUNJARO MOUNJARO KWIKPEN | Approved 2026-08-27: MOUNJARO; MOUNJARO (AUTOINJECTOR); MOUNJARO KWIKPEN (NDA215866 SUPPL45) |
| 2026-08-27 | FDA approval | approved | GILEAD SCIENCES INC GILD | BIXLENVO | Approved 2026-08-27: BIXLENVO (NDA221104 ORIG1) |
| 2026-08-27 | FDA approval | approved | GILEAD SCIENCES INC GILD | BIXLENVO SUNLENCA STARTER PACK | Approved 2026-08-27: BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) (NDA221443 ORIG1) |
| 2026-08-27 | FDA approval | approved | GILEAD SCIENCES INC GILD | SUNLENCA | Approved 2026-08-27: SUNLENCA (NDA215973 SUPPL24) |
| 2026-08-27 | FDA approval | approved | GILEAD SCIENCES INC GILD | SUNLENCA | Approved 2026-08-27: SUNLENCA (NDA215974 SUPPL17) |
| 2026-08-27 | FDA approval | approved | PRIOVANT THERAP | LISRAYA | Approved 2026-08-27: LISRAYA (NDA220106 ORIG1) |
| 2026-08-26 | FDA approval | approved | ELI LILLY AND CO LLY | ZEPBOUND ZEPBOUND KWIKPEN | Approved 2026-08-26: ZEPBOUND; ZEPBOUND (AUTOINJECTOR); ZEPBOUND KWIKPEN (NDA217806 SUPPL41) |
| 2026-08-26 | FDA approval | approved | REVOLUTION MEDICINES RVMD | RASONQUE | Approved 2026-08-26: RASONQUE (NDA220910 ORIG1) |
| 2026-08-26 | FDA approval | approved | SUN PHARM | VOBRIG | Approved 2026-08-26: VOBRIG (NDA213225 ORIG1) |
| 2026-08-25 | FDA approval | approved | BEIGENE | TEVIMBRA | Approved 2026-08-25: TEVIMBRA (BLA761232 SUPPL18) |
| 2026-08-25 | FDA approval | approved | JAZZ PHARMS JAZZ | ZIIHERA | Approved 2026-08-25: ZIIHERA (BLA761416 SUPPL2) |
| 2026-08-25 | FDA approval | approved | VIIV HLTHCARE | TIVICAY | Approved 2026-08-25: TIVICAY (NDA204790 SUPPL34) |
| 2026-08-25 | FDA approval | approved | VIIV HLTHCARE | TIVICAY PD | Approved 2026-08-25: TIVICAY PD (NDA213983 SUPPL7) |
| 2026-08-25 | PDUFA date (company-disclosed) | date passed | Zymeworks Inc. ZYME | zanidatamab | PDUFA August 25, 2026 - Zymeworks Inc. (zanidatamab) |
| 2026-08-24 | FDA approval | approved | JANSSEN BIOTECH | IMAAVY | Approved 2026-08-24: IMAAVY (BLA761430 SUPPL2) |
| 2026-08-23 | PDUFA date (company-disclosed) | date passed | Ultragenyx Pharmaceutical Inc. RARE | rebisufligene | PDUFA August 23, 2026 - Ultragenyx Pharmaceutical Inc. (rebisufligene) |
| 2026-08-20 | FDA approval | approved | APELLIS PHARMS | EMPAVELI | Approved 2026-08-20: EMPAVELI (NDA215014 SUPPL12) |
| 2026-08-19 | FDA approval | approved | REGENERON PHARMACEUTICALS, INC REGN | PASATRU | Approved 2026-08-19: PASATRU (BLA761508 ORIG1) |
| 2026-08-18 | Complete response letter | complete response | SamChunDang Pharm. Co., Ltd. | SCD411 | CRL 2026-08-18: SamChunDang Pharm. Co., Ltd. BLA 761494 (SCD411) |
| 2026-08-18 | Complete response letter | complete response | Xspray Pharma AB | | CRL 2026-08-18: Xspray Pharma AB NDA 216195 |
| 2026-08-14 | FDA approval | approved | BIOCON BIOLOGICS INC | YESINTEK | Approved 2026-08-14: YESINTEK (BLA761406 SUPPL2) |
| 2026-08-14 | FDA approval | approved | BAXTER HLTHCARE CORP BAX | SODIUM BICARBONATE | Approved 2026-08-14: SODIUM BICARBONATE (NDA218524 ORIG1) |
| 2026-08-13 | FDA approval | approved | CERVEAU LANTHEUS | TAUKLARIFY | Approved 2026-08-13: TAUKLARIFY (NDA220496 ORIG1) |
| 2026-08-13 | FDA approval | approved | BRISTOL MYERS SQUIBB BMY | ZENBEXUS | Approved 2026-08-13: ZENBEXUS (NDA221075 ORIG1) |
| 2026-08-09 | FDA approval | approved | LINDE GAS EQUIP LIN | NITROUS OXIDE USP | Approved 2026-08-09: NITROUS OXIDE, USP (NDA221892 ORIG1) |
| 2026-08-07 | Complete response letter | complete response | ITM Solucin GmbH | MPA | CRL 2026-08-07: ITM Solucin GmbH NDA 218705 (MPA (Iutetium Lu177 edotreotide) injection) |
| 2026-08-05 | FDA approval | approved | TAKEDA PHARMS USA TAK | ORZEYFUL | Approved 2026-08-05: ORZEYFUL (NDA220860 ORIG1) |
| 2026-08-05 | PDUFA date (company-disclosed) | date passed | Moderna, Inc. MRNA | | PDUFA August 5 - Moderna, Inc. |
| 2026-07-31 | FDA approval | approved | NOVARTIS NVS | PLUVICTO | Approved 2026-07-31: PLUVICTO (NDA215833 SUPPL37) |
| 2026-07-31 | FDA approval | approved | DR REDDYS LABS SA | ZIMRIXBY | Approved 2026-07-31: ZIMRIXBY (BLA761376 ORIG1) |
| 2026-07-30 | FDA AdCom | held | Replimune, Inc. REPL | | AdCom 2026-07-30: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125827 |
| 2026-07-30 | FDA AdCom | held | Replimune, Inc. REPL | | AdCom 2026-07-30: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125827 |
| 2026-07-29 | FDA AdCom | held | Capricor, Inc. CAPR | | AdCom 2026-07-29: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125842 |
| 2026-07-29 | FDA AdCom | held | Capricor, Inc. CAPR | | AdCom 2026-07-29: Cellular, Tissue, and Gene Therapies Advisory Committee - BLA 125842 |
| 2026-07-29 | Complete response letter | approved since | Fresenius Kabi USA, LLC | Glycophos | CRL 2026-07-29: Fresenius Kabi USA, LLC NDA 220381/Original 2, NDA 220381 (Glycophos (sodium glycerophosphate injection)) |
| 2026-07-29 | FDA approval | approved | FRESENIUS KABI USA | GLYCOPHOS | Approved 2026-07-29: GLYCOPHOS (NDA220381 ORIG1) |
| 2026-07-29 | FDA approval | approved | CMP DEV LLC | QLONILIK | Approved 2026-07-29: QLONILIK (NDA221094 ORIG1) |
| 2026-07-29 | PDUFA date (company-disclosed) | date passed | Outlook Therapeutics, Inc. OTLK | bevacizumab-vikg | PDUFA July 29, 2026 - Outlook Therapeutics, Inc. (bevacizumab-vikg) |
| 2026-07-28 | FDA approval | approved | VIATRIS SPECIALTY VTRS | GWYN LO | Approved 2026-07-28: GWYN LO (NDA219990 ORIG1) |
| 2026-07-24 | FDA approval | approved | ASTELLAS | XTANDI | Approved 2026-07-24: XTANDI (NDA213674 SUPPL16) |
| 2026-07-24 | FDA approval | approved | OUTLOOK THERAPEUTICS, INC. OTLK | LYTENAVA | Approved 2026-07-24: LYTENAVA (BLA761320 ORIG1) |
| 2026-07-24 | FDA approval | approved | KENVUE BRANDS | TYLENOL WITH NAPROXEN | Approved 2026-07-24: TYLENOL WITH NAPROXEN (NDA219962 ORIG1) |
| 2026-07-24 | FDA approval | approved | MERIDIAN BIOSCIENCE MRBK | IDKIT:HP | Approved 2026-07-24: IDKIT:HP (NDA021314 SUPPL14) |
| 2026-07-24 | FDA approval | approved | EMERGE BIOSCIENCE PTE. LTD. | GARZULYS | Approved 2026-07-24: GARZULYS (BLA761497 ORIG1) |
| 2026-07-24 | FDA approval | approved | OTSUKA | SIMTRIYO | Approved 2026-07-24: SIMTRIYO (NDA218145 ORIG1) |
| 2026-07-24 | FDA approval | approved | ASTELLAS | XTANDI | Approved 2026-07-24: XTANDI (NDA203415 SUPPL26) |
| 2026-07-23 | FDA AdCom | held | | | AdCom 2026-07-23: Pharmacy Compounding Advisory Committee |
| 2026-07-23 | FDA approval | approved | SCPHARMACEUTICALS | FUROSCIX FUROSCIX READYFLOW | Approved 2026-07-23: FUROSCIX; FUROSCIX READYFLOW (AUTOINJECTOR) (NDA209988 SUPPL7) |
| 2026-07-23 | FDA approval | approved | AETERNA ZENTARIS | MACRILEN | Approved 2026-07-23: MACRILEN (NDA205598 SUPPL5) |
| 2026-07-22 | FDA approval | approved | NUVALENT | JIDEYTRO | Approved 2026-07-22: JIDEYTRO (NDA220185 ORIG1) |
| 2026-07-21 | Complete response letter | complete response | Apiject Systems Corp. | glycopyrrolate | CRL 2026-07-21: Apiject Systems Corp. NDA 219107 (glycopyrrolate solution) |
| 2026-07-19 | FDA approval | approved | NOBLE GAS SOLUTIONS INC. NE | AIR | Approved 2026-07-19: AIR (NDA221805 ORIG1) |
| 2026-07-16 | FDA approval | approved | MUNDIPHARMA | REZZAYO | Approved 2026-07-16: REZZAYO (NDA217417 SUPPL7) |
| 2026-07-16 | FDA approval | approved | NOVARTIS NVS | FABHALTA | Approved 2026-07-16: FABHALTA (NDA218276 SUPPL7) |
| 2026-07-16 | FDA approval | approved | SUN PHARMA GLOBAL | ILUMYA | Approved 2026-07-16: ILUMYA (BLA761067 SUPPL27) |
| 2026-07-15 | FDA approval | approved | MSD | LIPFENDRA | Approved 2026-07-15: LIPFENDRA (NDA220848 ORIG1) |
| 2026-07-14 | FDA approval | approved | CELCUITY CELC | REVTORPYK | Approved 2026-07-14: REVTORPYK (NDA219908 ORIG1) |
| 2026-07-14 | FDA approval | approved | ELI LILLY AND CO LLY | RETEVMO | Approved 2026-07-14: RETEVMO (NDA218160 SUPPL7) |
| 2026-07-14 | FDA approval | approved | ELI LILLY AND CO LLY | RETEVMO | Approved 2026-07-14: RETEVMO (NDA213246 SUPPL17) |
| 2026-07-13 | FDA approval | approved | EISAI INC | LEQEMBI IQLIK | Approved 2026-07-13: LEQEMBI IQLIK (BLA761375 SUPPL1) |
| 2026-07-13 | FDA approval | approved | ELI LILLY AND CO LLY | VERZENIO | Approved 2026-07-13: VERZENIO (NDA208716 SUPPL21) |
| 2026-07-10 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA | Approved 2026-07-10: KEYTRUDA (BLA125514 SUPPL194) |
| 2026-07-10 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA QLEX | Approved 2026-07-10: KEYTRUDA QLEX (BLA761467 SUPPL12) |
| 2026-07-10 | FDA approval | approved | PROVEPHARM SAS | ZYOGREEN | Approved 2026-07-10: ZYOGREEN (NDA218579 ORIG1) |
| 2026-07-10 | FDA approval | approved | ASTELLAS | PADCEV | Approved 2026-07-10: PADCEV (BLA761137 SUPPL37) |
| 2026-07-09 | Complete response letter | complete response | Jiangsu Hengrui Pharmaceuticals Co., Ltd. JHPCY | SHR- 1210 | CRL 2026-07-09: Jiangsu Hengrui Pharmaceuticals Co., Ltd. BLA 761308 (SHR- 1210 injection) |
| 2026-07-09 | Complete response letter | complete response | Elevar Therapeutics Inc. | rivoceranib | CRL 2026-07-09: Elevar Therapeutics Inc. NDA 216586 (rivoceranib tablet) |
| 2026-07-09 | FDA approval | approved | AMNEAL AMRX | SODIUM BICARBONATE | Approved 2026-07-09: SODIUM BICARBONATE (NDA220790 ORIG1) |
| 2026-07-09 | FDA approval | approved | SANOFI-AVENTIS U.S. LLC SNY | SARCLISA ESCENA | Approved 2026-07-09: SARCLISA ESCENA (BLA761445 ORIG1) |
| 2026-07-07 | FDA approval | approved | GLENMARK SPECLT | RYALTRIS | Approved 2026-07-07: RYALTRIS (NDA211746 SUPPL11) |
| 2026-07-07 | FDA approval | approved | VERA THERAPEUTICS INC. VERA | TRUTAKNA | Approved 2026-07-07: TRUTAKNA (BLA761486 ORIG1) |
| 2026-07-02 | Complete response letter | complete response | Ascelia Pharma AB | (PN) (manganese chloride tetrahydrate — powder for oral solution) | CRL 2026-07-02: Ascelia Pharma AB NDA 220544 ((PN) (manganese chloride tetrahydrate — powder for oral solution)) |
| 2026-07-01 | FDA approval | approved | NOVARTIS NVS | KISQALI FEMARA CO-PACK | Approved 2026-07-01: KISQALI FEMARA CO-PACK (COPACKAGED) (NDA209935 SUPPL33) |
| 2026-07-01 | FDA approval | approved | NOVARTIS NVS | KISQALI | Approved 2026-07-01: KISQALI (NDA209092 SUPPL27) |
| 2026-07-01 (month) | PDUFA date (company-disclosed) | date passed | Immunome Inc. IMNM | varegacestat | PDUFA July 2026 - Immunome Inc. (varegacestat) |
| 2026-07-01 (half) | PDUFA date (company-disclosed) | date passed | Ultragenyx Pharmaceutical Inc. RARE | | PDUFA second half of 2026 - Ultragenyx Pharmaceutical Inc. |
| 2026-06-29 | Complete response letter | complete response | Unicycive Therapeutics Inc. UNCY | oxylanthanum carbonate | CRL 2026-06-29: Unicycive Therapeutics Inc. NDA 218607 (oxylanthanum carbonate tablets) |
| 2026-06-29 | Complete response letter | complete response | Ipsen Biopharm Ltd. | relabotulinumtoxin A | CRL 2026-06-29: Ipsen Biopharm Ltd. BLA 761311 (relabotulinumtoxin A injection) |
| 2026-06-29 | FDA approval | approved | ARCUTIS ARQT | ZORYVE | Approved 2026-06-29: ZORYVE (NDA215985 SUPPL15) |
| 2026-06-26 | Complete response letter | complete response | Evergreen Theragnostics, Inc. | the Preparation of Gallium Ga Edotreotide | CRL 2026-06-26: Evergreen Theragnostics, Inc. NDA 216900 (the Preparation of Gallium Ga Edotreotide Injection) |
| 2026-06-26 | Complete response letter | complete response | Swedish Orphan Biovitrum AB (publ) | sirolimus for suspension | CRL 2026-06-26: Swedish Orphan Biovitrum AB (publ) BLA 761438 (sirolimus for injectable suspension) |
| 2026-06-26 | FDA approval | approved | DECIPHERA PHARMS | ROMVIMZA | Approved 2026-06-26: ROMVIMZA (NDA219304 SUPPL2) |
| 2026-06-26 | FDA approval | approved | VIRIDIAN THERAPEUTICS INC VRDN | LUMVOA | Approved 2026-06-26: LUMVOA (BLA761530 ORIG1) |
| 2026-06-26 | FDA approval | approved | ABBVIE INC ABBV | SKYRIZI | Approved 2026-06-26: SKYRIZI (BLA761105 SUPPL45) |
| 2026-06-25 | FDA approval | approved | MERZ PHARMS | Xeomin | Approved 2026-06-25: Xeomin (BLA125360 SUPPL108) |
| 2026-06-24 | FDA approval | approved | AVYXA HOLDINGS | NAVITRUX | Approved 2026-06-24: NAVITRUX (NDA220436 ORIG1) |
| 2026-06-24 | FDA approval | approved | PFIZER PFE | IBRANCE | Approved 2026-06-24: IBRANCE (NDA207103 SUPPL24) |
| 2026-06-24 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA | Approved 2026-06-24: KEYTRUDA (BLA125514 SUPPL187) |
| 2026-06-24 | FDA approval | approved | PFIZER PFE | IBRANCE | Approved 2026-06-24: IBRANCE (NDA212436 SUPPL12) |
| 2026-06-24 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA QLEX | Approved 2026-06-24: KEYTRUDA QLEX (BLA761467 SUPPL4) |
| 2026-06-24 | FDA approval | approved | IONIS PHARMS INC IONS | TRYNGOLZA | Approved 2026-06-24: TRYNGOLZA (AUTOINJECTOR) (NDA218614 SUPPL4) |
| 2026-06-24 | FDA approval | approved | IMMUNOMEDICS INC | TRODELVY | Approved 2026-06-24: TRODELVY (BLA761115 SUPPL64) |
| 2026-06-24 | FDA approval | approved | IMMUNOMEDICS INC | TRODELVY | Approved 2026-06-24: TRODELVY (BLA761115 SUPPL63) |
| 2026-06-23 | Complete response letter | complete response | Tanvex BioPharma USA, Inc. | | CRL 2026-06-23: Tanvex BioPharma USA, Inc. BLA 761266 |
| 2026-06-20 | Complete response letter | complete response | Achieve Life Sciences, Inc. QUIT | cytisinicline | CRL 2026-06-20: Achieve Life Sciences, Inc. NDA 218995 (cytisinicline tablet, ©) |
| 2026-06-18 | FDA AdCom | held | | | AdCom 2026-06-18: Vaccines and Related Biological Products Advisory Committee |
| 2026-06-18 | FDA approval | approved | ZEALAND PHARMA ZEAL.CO | ZEGALOGUE | Approved 2026-06-18: ZEGALOGUE; ZEGALOGUE (AUTOINJECTOR) (NDA214231 SUPPL4) |
| 2026-06-17 | Complete response letter | approved since | Avyxa Holdings, LLC | Cisplatin | CRL 2026-06-17: Avyxa Holdings, LLC NDA 220748 (Cisplatin Injection) |
| 2026-06-17 | FDA approval | approved | GLAXOSMITHKLINE | UTEBZI | Approved 2026-06-17: UTEBZI (NDA215960 ORIG1) |
| 2026-06-16 | FDA approval | approved | AZURITY | APREPITANT | Approved 2026-06-16: APREPITANT (NDA218754 ORIG1) |
| 2026-06-16 | FDA approval | approved | AMPHASTAR PHARMS INC AMPH | REXTOVY | Approved 2026-06-16: REXTOVY (NDA208969 SUPPL2) |
| 2026-06-15 | Complete response letter | complete response | Tris Pharma, Inc. | oxybate for powder for suspension | CRL 2026-06-15: Tris Pharma, Inc. NDA 220138 (oxybate for extended-release powder for oral suspension (oxybate ER OS)) |
| 2026-06-12 | FDA approval | approved | PROVENTION BIO INC | TZIELD | Approved 2026-06-12: TZIELD (BLA761183 SUPPL10) |
| 2026-06-12 | FDA approval | approved | MERCK SHARP DOHME MRK | WELIREG | Approved 2026-06-12: WELIREG (NDA215383 SUPPL15) |
| 2026-06-12 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA | Approved 2026-06-12: KEYTRUDA (BLA125514 SUPPL192) |
| 2026-06-12 | FDA approval | approved | MERCK SHARP DOHME MRK | KEYTRUDA QLEX | Approved 2026-06-12: KEYTRUDA QLEX (BLA761467 SUPPL9) |
| 2026-06-12 | FDA approval | approved | BAYER HEALTHCARE | AMBELVIST | Approved 2026-06-12: AMBELVIST (NDA219627 ORIG1) |
| 2026-06-12 | FDA approval | approved | ABBVIE INC ABBV | SKYRIZI | Approved 2026-06-12: SKYRIZI (BLA761105 SUPPL44) |
| 2026-06-12 | FDA approval | approved | ASTRAZENECA AZN | TRUQAP | Approved 2026-06-12: TRUQAP (NDA218197 SUPPL4) |
| 2026-06-11 | FDA approval | approved | HOFFMANN-LA ROCHE | ALECENSA | Approved 2026-06-11: ALECENSA (NDA208434 SUPPL16) |
| 2026-06-10 | Complete response letter | complete response | Bridge Regulatory Affairs, LLC | octreotide hydrochloride extended- release | CRL 2026-06-10: Bridge Regulatory Affairs, LLC NDA 218600 (octreotide hydrochloride extended- release injection) |
| 2026-06-09 | FDA approval | approved | ELI LILLY AND CO LLY | EBGLYSS | Approved 2026-06-09: EBGLYSS (BLA761306 SUPPL6) |
| 2026-06-05 | FDA approval | approved | PFIZER INC PFE | HYMPAVZI | Approved 2026-06-05: HYMPAVZI (BLA761369 SUPPL3) |
| 2026-06-04 | Complete response letter | complete response | Xspray Pharma AB | (9) (nilotinib) capsules | CRL 2026-06-04: Xspray Pharma AB NDA 217644 ((9) (nilotinib) capsules) |
| 2026-06-02 | FDA approval | approved | CASPER PHARMA LLC | TIOCYSTIN | Approved 2026-06-02: TIOCYSTIN (NDA212927 ORIG1) |
| 2026-06-02 | FDA approval | approved | LUPIN LIMITED | RANLUSPEC | Approved 2026-06-02: RANLUSPEC (BLA761480 ORIG1) |
| 2026-05-29 | Complete response letter | complete response | Cingulate Therapeutics, LLC CING | dexmethylphenidate hydrochloride | CRL 2026-05-29: Cingulate Therapeutics, LLC NDA 220283 (dexmethylphenidate hydrochloride extended-release tablets) |
| 2026-05-29 | FDA approval | approved | SHIONOGI | XOCOVA | Approved 2026-05-29: XOCOVA (NDA220442 ORIG1) |
| 2026-05-29 | FDA approval | approved | HAISCO | CYPSEDO | Approved 2026-05-29: CYPSEDO (NDA220482 ORIG1) |
| 2026-05-29 | FDA approval | approved | WOCKHARDT BIO AG | ZAYNICH | Approved 2026-05-29: ZAYNICH (NDA220787 ORIG1) |
| 2026-05-29 | FDA approval | approved | MANNKIND MNKD | AFREZZA | Approved 2026-05-29: AFREZZA (BLA022472 SUPPL29) |
| 2026-05-29 | FDA approval | approved | CYCLE | CAVHANZA | Approved 2026-05-29: CAVHANZA (NDA217379 ORIG1) |
| 2026-05-28 | FDA AdCom | held | | | AdCom 2026-05-28: Vaccines and Related Biological Products Advisory Committee |
| 2026-05-28 | FDA approval | approved | JANSSEN BIOTECH | TREMFYA | Approved 2026-05-28: TREMFYA (BLA761061 SUPPL34) |
| 2026-05-28 | FDA approval | approved | ASTRAZENECA UK LTD AZN | IMFINZI | Approved 2026-05-28: IMFINZI (BLA761069 SUPPL53) |
| 2026-05-27 | FDA approval | approved | ABBVIE INC ABBV | DECNUPAZ | Approved 2026-05-27: DECNUPAZ (BLA761460 ORIG1) |
| 2026-05-23 | FDA approval | approved | ACTELION | UPTRAVI | Approved 2026-05-23: UPTRAVI (NDA207947 SUPPL14) |